Evidence map›Paper›PMID 22685571›Full record

ArticlePloS one2012

saeRS and sarA act synergistically to repress protease production and promote biofilm formation in Staphylococcus aureus.

Lara N Mrak, Agnieszka K Zielinska, Karen E Beenken, Ian N Mrak, Danielle N Atwood, Linda M Griffin, Chia Y Lee, Mark S Smeltzer

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 87 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Biofilm-associated genes inFrontiers in microbiology · 2026
    Review
  6. Article
  7. Article
  8. Microorganisms · 2025
    Review
  9. Microorganisms · 2025
    Article
  10. Frontiers in microbiology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Staphylococcal mastitis in dairy cows.Frontiers in veterinary science · 2024
    Review
  15. Molecules (Basel, Switzerland) · 2023
    Article
  16. Review
  17. A Review of Biofilm Formation ofAntibiotics (Basel, Switzerland) · 2022
    Review
  18. Article
  19. Bacterial toxins in musculoskeletal infections.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2021
    Review
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Lara N MrakDepartment of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America.
Agnieszka K Zielinska
Karen E Beenken
Ian N Mrak
Danielle N Atwood
Linda M Griffin
Chia Y Lee
Mark S Smeltzer
University of Arkansas for Medical Sciences · US

Funding

Regulation of Staphylococcus aureus biofilm by RbfR01AI067857 · NIAID · UNIV OF ARKANSAS FOR MED SCIS · PI LEE, CHIA Y. · 2007 to 2011
$1.8M
Regulation of biofilm formation in clinical isolates of Staphylococcus aureusR01AI074935 · NIAID · UNIV OF ARKANSAS FOR MED SCIS · PI SMELTZER, MARK S · 2007 to 2011
$1.6M
NCRR NIH HHS RR0298884NIAID NIH HHS R01 AI067857NIAID NIH HHS R01 AI074935NIAID NIH HHS R01-AI074935
6 · The paper itself

Abstract

Mutation of the staphylococcal accessory regulator (sarA) limits biofilm formation in diverse strains of Staphylococcus aureus, but there are exceptions. One of these is the commonly studied strain Newman. This strain has two defects of potential relevance, the first being mutations that preclude anchoring of the fibronectin-binding proteins FnbA and FnbB to the cell wall, and the second being a point mutation in saeS that results in constitutive activation of the saePQRS regulatory system. We repaired these defects to determine whether either plays a role in biofilm formation and, if so, whether this could account for the reduced impact of sarA in Newman. Restoration of surface-anchored FnbA enhanced biofilm formation, but mutation of sarA in this fnbA-positive strain increased rather than decreased biofilm formation. Mutation of sarA in an saeS-repaired derivative of Newman (P18L) or a Newman saeRS mutant (ΔsaeRS) resulted in a biofilm-deficient phenotype like that observed in clinical isolates, even in the absence of surface-anchored FnbA. These phenotypes were correlated with increased production of extracellular proteases and decreased accumulation of FnbA and/or Spa in the P18L and ΔsaeRS sarA mutants by comparison to the Newman sarA mutant. The reduced accumulation of Spa was reversed by mutation of the gene encoding aureolysin, while the reduced accumulation of FnbA was reversed by mutation of the sspABC operon. These results demonstrate that saeRS and sarA act synergistically to repress the production of extracellular proteases that would otherwise limit accumulation of critical proteins that contribute to biofilm formation, with constitutive activation of saeRS limiting protease production, even in a sarA mutant, to a degree that can be correlated with increased enhanced capacity to form a biofilm. Although it remains unclear whether these effects are mediated directly or indirectly, studies done with an sspA::lux reporter suggest they are mediated at a transcriptional level.

Indexed as

Adhesins, BacterialBacterial ProteinsBiofilmsBlotting, WesternExtracellular SpaceGene Expression Regulation, BacterialMetalloendopeptidasesMutationPeptide HydrolasesPhenotypeProtein KinasesReverse Transcriptase Polymerase Chain ReactionStaphylococcus aureusTrans-ActivatorsTranscription FactorsAdhesins, BacterialaureolysinBacterial Proteinsfibronectin-binding proteins, bacterialMetalloendopeptidasesPeptide HydrolasesProtein KinasesSaeR protein, Staphylococcus aureusSaeS protein, Staphylococcus aureusSarA protein, bacterialTrans-ActivatorsTranscription Factors

Identifiers

PMID22685571
PMCPMC3369899
OpenAlexW2016045705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.